QNASL is a Nasal Aerosol, Metered in the Human Prescription Drug category. It is labeled and distributed by Teva Respiratory, Llc. The primary component is Beclomethasone Dipropionate.
| Product ID | 59310-206_357352cc-327d-4c62-a4d6-e60a0748bed4 |
| NDC | 59310-206 |
| Product Type | Human Prescription Drug |
| Proprietary Name | QNASL |
| Generic Name | Beclomethasone Dipropionate |
| Dosage Form | Aerosol, Metered |
| Route of Administration | NASAL |
| Marketing Start Date | 2015-02-01 |
| Marketing Category | NDA / NDA |
| Application Number | NDA202813 |
| Labeler Name | Teva Respiratory, LLC |
| Substance Name | BECLOMETHASONE DIPROPIONATE |
| Active Ingredient Strength | 40 ug/1 |
| Pharm Classes | Corticosteroid [EPC],Corticosteroid Hormone Receptor Agonists [MoA] |
| NDC Exclude Flag | N |
| Listing Certified Through | 2019-12-31 |
| Marketing Start Date | 2015-02-02 |
| NDC Exclude Flag | N |
| Sample Package? | N |
| Marketing Category | NDA |
| Application Number | NDA202813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-02-01 |
| Marketing End Date | 2019-01-22 |
| Marketing Category | NDA |
| Application Number | NDA202813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-02-01 |
| Marketing End Date | 2015-02-01 |
| Marketing Category | NDA |
| Application Number | NDA202813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Marketing Start Date | 2015-02-01 |
| Marketing End Date | 2015-02-01 |
| Marketing Category | NDA |
| Application Number | NDA202813 |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Billing Unit | GM |
| Marketing Start Date | 2015-02-02 |
| Marketing End Date | 2019-10-17 |
| Ingredient | Strength |
|---|---|
| BECLOMETHASONE DIPROPIONATE | 40 ug/1 |
| SPL SET ID: | 3be74938-3281-4586-a57c-2501e8a06960 |
| Manufacturer | |
| UNII | |
| RxNorm Concept Unique ID - RxCUI |
| NDC | Brand Name | Generic Name |
|---|---|---|
| 59310-206 | QNASL | Beclomethasone Dipropionate |
| 59310-210 | QNASL | Beclomethasone Dipropionate |
| 59310-406 | QNASL | Beclomethasone Dipropionate |
| 59310-410 | QNASL | Beclomethasone dipropionate |
| 50090-1342 | QVAR | Beclomethasone Dipropionate |
| 50090-3033 | QVAR | Beclomethasone Dipropionate |
| 59310-202 | QVAR | Beclomethasone Dipropionate |
| 59310-204 | QVAR | Beclomethasone Dipropionate |
| 68071-1691 | QVAR | Beclomethasone Dipropionate |
| 68788-7025 | QVAR | beclomethasone dipropionate |
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
![]() QNASL 97041779 not registered Live/Pending |
TEVA PHARMACEUTICALS USA, Inc. 2021-09-23 |
![]() QNASL 97041776 not registered Live/Pending |
TEVA PHARMACEUTICALS USA, Inc. 2021-09-23 |
![]() QNASL 85621560 4210215 Live/Registered |
TEVA RESPIRATORY, LLC 2012-05-10 |
![]() QNASL 85621557 4210214 Live/Registered |
TEVA RESPIRATORY, LLC 2012-05-10 |
![]() QNASL 85404349 not registered Dead/Abandoned |
TEVA RESPIRATORY, LLC 2011-08-23 |
![]() QNASL 85404341 not registered Dead/Abandoned |
TEVA RESPIRATORY, LLC 2011-08-23 |
![]() QNASL 85308405 4172769 Live/Registered |
TEVA RESPIRATORY, LLC 2011-04-29 |